{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:28:01Z","timestamp":1760956081249,"version":"3.38.0"},"reference-count":179,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Medical Devices"],"published-print":{"date-parts":[[2021,5,4]]},"DOI":"10.1080\/17434440.2021.1915764","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:57:10Z","timestamp":1618034230000},"page":"457-471","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Mortality in mechanically ventilated patients with COVID-19: a systematic review"],"prefix":"10.1080","volume":"18","author":[{"given":"Maria","family":"Tsikala Vafea","sequence":"first","affiliation":[{"name":"Warren Alpert Medical School of Brown University","place":["Providence, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raina","family":"Zhang","sequence":"additional","affiliation":[{"name":"Warren Alpert Medical School of Brown University","place":["Providence, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markos","family":"Kalligeros","sequence":"additional","affiliation":[{"name":"Warren Alpert Medical School of Brown University","place":["Providence, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia K.","family":"Mylona","sequence":"additional","affiliation":[{"name":"Warren Alpert Medical School of Brown University","place":["Providence, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Shehadeh","sequence":"additional","affiliation":[{"name":"Warren Alpert Medical School of Brown University","place":["Providence, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[{"name":"Warren Alpert Medical School of Brown University","place":["Providence, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30161-2"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104371"},{"key":"e_1_3_5_4_1","unstructured":"[cited 2020 Aug 20]. Available from:https:\/\/www.covid19treatmentguidelines.nih.gov\/critical-care\/oxygenation-and-ventilation\/"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06022-5"},{"issue":"23","key":"e_1_3_5_6_1","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Ranieri VM","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Thompson BT. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526\u20132533. Force* TADT.","journal-title":"JAMA"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30304-0"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06033-2"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2020.103455"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0291"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.06.014"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25964"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100448"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072282"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104899"},{"issue":"3","key":"e_1_3_5_17_1","first-page":"396","article-title":"The first two months of the COVID-19 pandemic in Bosnia and Herzegovina: single-center experience","volume":"20","author":"Arapovic J","year":"2020","unstructured":"Arapovic J, Skocibusic S. The first two months of the COVID-19 pandemic in Bosnia and Herzegovina: single-center experience. Bosn J Basic Med Sci. 2020 Aug 3;20(3):396\u2013400.","journal-title":"Bosn J Basic Med Sci"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1996"},{"key":"e_1_3_5_19_1","article-title":"ICU and ventilator mortality among critically ill adults with coronavirus disease 2019","author":"Auld SC","unstructured":"Auld SC, Caridi-Scheible M, Blum JM, et al. ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med. 2020 Sep;48(9):e799-e804.","journal-title":"Crit Care Med"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.04.001"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.024"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004500"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05658-9"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01665-z"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa243"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02924-4"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05180-x"},{"volume-title":"Clin Microbiol Infect","author":"Cen Y","key":"e_1_3_5_28_1","unstructured":"Cen Y, Chen X, Shen Y, et al. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study. Clin Microbiol Infect."},{"key":"e_1_3_5_29_1","first-page":"4(2):e40","article-title":"Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China","author":"Chen F","year":"2020","unstructured":"Chen F, Sun W, Sun S, et al. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China. Clin Transl Med. 2020 Jun;4(2):e40.","journal-title":"Clin Transl Med"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.07.003"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0911-0"},{"key":"e_1_3_5_32_1","article-title":"Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study","author":"Chen T","unstructured":"Chen T, Dai Z, Mo P, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol A Biol Sci Med Sci.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1091"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31189-2"},{"key":"e_1_3_5_35_1","article-title":"High flow nasal canula in critically ill severe COVID-19 patients","author":"Demoule A","unstructured":"Demoule A, Vieillard Baron A, Darmon M, et al. High flow nasal canula in critically ill severe COVID-19 patients. Am J Respir Crit Care Med.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1985"},{"issue":"3","key":"e_1_3_5_37_1","first-page":"3","article-title":"Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study","volume":"289","author":"Eimer J","year":"2020","unstructured":"Eimer J, Vesterbacka J, Svensson AK, et al. Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study. J Intern Med. 2020 Aug;289(3):3.","journal-title":"J Intern Med"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2020.102867"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-1582LE"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.07.001"},{"key":"e_1_3_5_41_1","article-title":"Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS","author":"Ferrando C","unstructured":"Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med.","journal-title":"Intensive Care Med"},{"key":"e_1_3_5_42_1","first-page":"1","article-title":"Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID-19 patients with acute kidney injury and renal replacement therapy","volume":"13","author":"Fominskiy EV","year":"2020","unstructured":"Fominskiy EV, Scandroglio AM, Monti G, et al. Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID-19 patients with acute kidney injury and renal replacement therapy. Blood Purif. 2020;13:1\u20138.","journal-title":"Blood Purif"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103631"},{"issue":"2","key":"e_1_3_5_44_1","first-page":"8","article-title":"Clinical characteristics, outcomes and prognosticators in adult patients hospitalized with COVID-19","volume":"49","author":"Gavin W","year":"2020","unstructured":"Gavin W, Campbell E, Zaidi SA, et al. Clinical characteristics, outcomes and prognosticators in adult patients hospitalized with COVID-19. Am J Infect Control. 2020 Jul;49(2):8.","journal-title":"Am J Infect Control"},{"key":"e_1_3_5_45_1","article-title":"Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York","author":"Gayam V","unstructured":"Gayam V, Chobufo MD, Merghani MA, et al. Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York. J Med Virol.","journal-title":"J Med Virol"},{"issue":"2","key":"e_1_3_5_46_1","first-page":"24","article-title":"Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study","volume":"93","author":"Van Gerwen M","year":"2020","unstructured":"Van Gerwen M, Alsen M, Little C, et al. Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study. J Med Virol. 2020 Jul;93(2):24.","journal-title":"J Med Virol"},{"key":"e_1_3_5_47_1","article-title":"Remdesivir for 5 or 10 Days in Patients with Severe Covid-19","author":"Goldman JD","unstructured":"Goldman JD, Lye DCB, Hui DS, et al. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med.","journal-title":"N Engl J Med"},{"key":"e_1_3_5_48_1","article-title":"COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study","author":"Gotzinger F","unstructured":"Gotzinger F, Santiago-Garcia B, Noguera-Julian A et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Lancet Child Adolesc Health.","journal-title":"Lancet Child Adolesc Health"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3539"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007016"},{"key":"e_1_3_5_51_1","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US","author":"Gupta S","unstructured":"Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med.","journal-title":"JAMA Intern Med"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108331"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-020-2227-8"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03044-9"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa388"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2020-0013"},{"key":"e_1_3_5_57_1","article-title":"Compassionate use of tocilizumab for treatment of SARS-CoV-2 pneumonia","author":"Jordan SC","unstructured":"Jordan SC, Zakowski P, Tran HP, et al. Compassionate use of tocilizumab for treatment of SARS-CoV-2 pneumonia. Clin Infect Dis.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_58_1","article-title":"Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study","author":"Karagiannidis C","unstructured":"Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med.","journal-title":"Lancet Respir Med"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2020.05.005"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.06.027"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1012"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26191"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31187-9"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.17.2000556"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e223"},{"key":"e_1_3_5_66_1","article-title":"Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19","author":"Li J","unstructured":"Li J, Li M, Zheng S, et al. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark Med.","journal-title":"Biomark Med"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46569"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0910-1"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00706-3"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021012"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14869"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.2196\/20548"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0516"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200794"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102523"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102512"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.07.012"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.07.001"},{"key":"e_1_3_5_79_1","article-title":"The Epidemiology of SARS-CoV-2 in a Pediatric Healthcare Network in the United States","author":"Otto WR","unstructured":"Otto WR, Geoghegan S, Posch LC, et al. The Epidemiology of SARS-CoV-2 in a Pediatric Healthcare Network in the United States. J Pediatric Infect Dis Soc.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.001"},{"issue":"5","key":"e_1_3_5_81_1","first-page":"5","article-title":"Initial experiences from patients with COVID-19 on ventilatory support in Denmark","volume":"67","author":"Pedersen HP","year":"2020","unstructured":"Pedersen HP, Hildebrandt T, Poulsen A, et al. Initial experiences from patients with COVID-19 on ventilatory support in Denmark. Dan Med J. 2020 Apr 27;67(5):5.","journal-title":"Dan Med J"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15941"},{"key":"e_1_3_5_83_1","article-title":"Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study","author":"Perez-Guzman PN","unstructured":"Perez-Guzman PN, Daunt A, Mukherjee S, et al. Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study. Clin Infect Dis.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16192"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1966"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.04.060"},{"issue":"4","key":"e_1_3_5_87_1","first-page":"15","article-title":"Tocilizumab treatment for cytokine release syndrome in hospitalized COVID-19 patients: survival and clinical outcomes","volume":"158","author":"Price CC","year":"2020","unstructured":"Price CC, Altice FL, Shyr Y, et al. Tocilizumab treatment for cytokine release syndrome in hospitalized COVID-19 patients: survival and clinical outcomes. Chest. 2020 Jun;158(4):15.","journal-title":"Chest"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa2011686"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000173"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104444"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-020-00565-9"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01683-0"},{"key":"e_1_3_5_93_1","article-title":"Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report","author":"Group RC","unstructured":"Group RC, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med.","journal-title":"N Engl J Med"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcaa206"},{"volume-title":"J Med Virol","author":"Salacup G","key":"e_1_3_5_96_1","unstructured":"Salacup G, Lo KB, Gul F, et al. Characteristics and clinical outcomes of COVID-19 patients in an underserved-inner city population: a single tertiary center cohort. J Med Virol."},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236778"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100426"},{"volume-title":"JAMA Pediatr","author":"Shekerdemian LS","key":"e_1_3_5_99_1","unstructured":"Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr."},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa408"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2020.05.011"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa954"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12270"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001585"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102568"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.27.20114090"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02895-6"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06047-w"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004473"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202003-0736LE"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.012"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03098-9"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46833"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30310-7"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004447"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230548"},{"key":"e_1_3_5_117_1","article-title":"Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy","author":"Zangrillo A","unstructured":"Zangrillo A, Beretta L, Scandroglio AM, et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc.","journal-title":"Crit Care Resusc"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-020-02778-8"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2020.05.012"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1163LE"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-020-02370-8"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.20.14785-0"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-2306"},{"key":"e_1_3_5_125_1","article-title":"Mortality from COVID-19: a cross-country comparison of containment versus mitigation strategy","author":"Chen YH","unstructured":"Chen YH, Fang CT. Mortality from COVID-19: a cross-country comparison of containment versus mitigation strategy. J Formos Med Assoc.","journal-title":"J Formos Med Assoc"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200715"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30192-2"},{"issue":"4","key":"e_1_3_5_128_1","first-page":"207","article-title":"[Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances.]","volume":"111","author":"Riccioni L","year":"2020","unstructured":"Riccioni L, Bertolini G, Giannini A, et al. [Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances.]. Recenti Prog Med. 2020 Apr;111(4):207\u2013211.","journal-title":"Recenti Prog Med"},{"key":"e_1_3_5_129_1","article-title":"Decreasing mortality rates in ICU during the COVID-19 pandemic","author":"Armstrong RA","unstructured":"Armstrong RA, Kane AD, Cook TM. Decreasing mortality rates in ICU during the COVID-19 pandemic. Anaesthesia.","journal-title":"Anaesthesia"},{"key":"e_1_3_5_130_1","unstructured":"https:\/\/www.cebm.net\/covid-19\/covid-19-declining-admissions-to-intensive-care-units\/[2020 Aug 20]."},{"key":"e_1_3_5_131_1","unstructured":"REGN-COV2 Independent data monitoring committee recommends holding enrollment in hospitalized patients with high oxygen requirements and continuing enrollment in patients with low or no oxygen requirements [internet]. Regeneron: PR Newswire; 2020; 2020 Oct 30. Available from: https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/regn-cov2-independent-data-monitoring-committee-recommends"},{"key":"e_1_3_5_132_1","unstructured":"Lilly Statement Regarding NIH\u2019s ACTIV-3 Clinical trial [Internet]. lilly.com: eli Lilly and company; 2020; 2020 Oct 26. Available from: https:\/\/www.lilly.com\/news\/stories\/statement-activ3-clinical-trial-nih-covid19"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa321"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa319"},{"key":"e_1_3_5_136_1","unstructured":"Pan H Peto R Karim QA et al. Repurposed antiviral drugs for COVID-19 \u2013interim WHO SOLIDARITY trial results."},{"key":"e_1_3_5_137_1","unstructured":"https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-legal-regulatory-and-policy-framework\/emergency-use-authorization#coviddrugs [2020 Aug 22]."},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.16349"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"e_1_3_5_141_1","unstructured":"https:\/\/www.nih.gov\/news-events\/news-releases\/nih-clinical-trial-hydroxychloroquine-potential-therapy-covid-19-begins [2020 Aug 20]."},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.07.018"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019014"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2016638"},{"key":"e_1_3_5_145_1","unstructured":"https:\/\/www.nih.gov\/news-events\/news-releases\/nih-halts-clinical-trial-hydroxychloroquine [2020 Aug 20]."},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237693"},{"key":"e_1_3_5_147_1","article-title":"Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience","volume":"2020","author":"Joyner MJ","unstructured":"Joyner MJ, Senefeld JW, Klassen SA, et al. Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience. medRxiv 2020.","journal-title":"medRxiv"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031893"},{"key":"e_1_3_5_149_1","article-title":"Effect of Convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","author":"Li L","unstructured":"Li L, Zhang W, Hu Y, et al. Effect of Convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA.","journal-title":"JAMA"},{"key":"e_1_3_5_150_1","article-title":"Treatment of COVID-19 patients with convalescent plasma reveals a signal of significantly decreased mortality","author":"Salazar E","unstructured":"Salazar E, Christensen PA, Graviss EA, et al. Treatment of COVID-19 patients with convalescent plasma reveals a signal of significantly decreased mortality. Am J Pathol.","journal-title":"Am J Pathol"},{"key":"e_1_3_5_151_1","unstructured":"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-issues-emergency-use-authorization-convalescent-plasma-potential-promising-covid-19-treatment [2020 Sept 2]."},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.16747"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17021"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.16761"},{"key":"e_1_3_5_155_1","article-title":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial","author":"Investigators T-C","unstructured":"Investigators T-C. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA.","journal-title":"JAMA"},{"key":"e_1_3_5_156_1","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","author":"Group TWREAfC-TW","unstructured":"Group TWREAfC-TW. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA.","journal-title":"JAMA"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1163"},{"key":"e_1_3_5_158_1","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase iib, placebo-controlled trial","author":"Jeronimo CMP","year":"2020","unstructured":"Jeronimo CMP, Farias MEL, Val FFA, et al. Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase iib, placebo-controlled trial. Clin Infect Dis. 2020:ciaa1177.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_159_1","unstructured":"COVID-19 treatment guidelines for corticosteroids: national institute of health; [updated November 3 2020;March 6 2021]. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/immunomodulators\/corticosteroids\/"},{"key":"e_1_3_5_160_1","unstructured":"[cited 2020 Sep 3]. Available from:https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Corticosteroids-2020.1"},{"key":"e_1_3_5_161_1","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial","volume":"2021","author":"Horby PW","unstructured":"Horby PW, Pessoa-Amorim G, Peto L, et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. medRxiv 2021.","journal-title":"medRxiv"},{"key":"e_1_3_5_162_1","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","author":"Investigators R-C","year":"2021","unstructured":"Investigators R-C. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. 2021.","journal-title":"N Engl J Med"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2020.07.002"},{"key":"e_1_3_5_164_1","article-title":"Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)","author":"Rodriguez-Bano J","unstructured":"Rodriguez-Bano J, Pachon J, Carratala J, et al. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19). Clin Microbiol Infect.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_5_165_1","unstructured":"The COVID-19 treatment guidelines panel\u2019s statement on the use of tocilizumab for the treatment of COVID-19: national institute of health; 2021 [updated March 5 2021;March 6 2021]. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/statement-on-tocilizumab\/"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.06.064"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02242-0"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.031"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.08.023"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009787"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04216-x"},{"key":"e_1_3_5_172_1","unstructured":"ATTACC ACTIV-4a & REMAP-CAP multiplatform RCT - Results of interim analysis [Presentation]. attacc.org: ATTACC; [updated January 28 2021;March 6 2021]. Available from: https:\/\/static1.squarespace.com\/static\/5f8f2c323fb81b0ae2ce3bca\/t\/60133c0962b8401f3885b537\/1611873291651\/mpRCT+interim+presentation_v21-slides+22+and+23+corrected+%281%29.pdf"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.041"},{"key":"e_1_3_5_174_1","unstructured":"Antithrombotic therapy in patients with COVID-19: national Institutes of Health; 2020 [updated February 11 2021;March 6 2021]. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/antithrombotic-therapy\/"},{"key":"e_1_3_5_175_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.44"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06346-w"},{"key":"e_1_3_5_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06323-9"},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30277-0"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066620940259"},{"key":"e_1_3_5_180_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01124"}],"container-title":["Expert Review of Medical Devices"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17434440.2021.1915764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:20:59Z","timestamp":1740745259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17434440.2021.1915764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":179,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,4]]}},"alternative-id":["10.1080\/17434440.2021.1915764"],"URL":"https:\/\/doi.org\/10.1080\/17434440.2021.1915764","relation":{},"ISSN":["1743-4440","1745-2422"],"issn-type":[{"type":"print","value":"1743-4440"},{"type":"electronic","value":"1745-2422"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}